If you want the broader landscape (and the list of other peptides driving search interest), see Metos internal piece: 14 Peptides Are About to Become Legal Again What This Means for Your Health. Who should consider AOD-9604 (and who shouldnt) Consider it only if your expectations are realistic AOD-9604 may be worth a conversation if you are: Already doing the fundamentals (protein, resistance training, sleep) Not seeking massive scale weight loss Looking at fat-loss support rather than appetite suppression Intolerant of GLP-1s and exploring alternatives (with the understanding that alternatives are usually less powerful) Avoid it if You have significant obesity and need a high-efficacy therapy (GLP-1/GIP class is typically far more impactful) (PubMed) Youre hoping it will melt fat without dietary alignment Your plan depends on unverified sources or research peptide suppliers Youre in a drug-tested sport environment (WADA prohibition is relevant) (wada-ama.org) Practical expectations (what most people want to know) How fast does it work
Public Docket FDA-2025-N-6895 Written comments on BPC-157 and the other peptides under review can be submitted to public docket FDA-2025-N-6895
Nallamothu BK, Wang Y, Cram P, Birkmeyer JD, Ross JS, Normand SL, Krumholz HM
Big Bazzar, 150ft Ring Road, Rajkot 360005 (Gujarat, India) / Plot No
doi: PubMed: 20869957
These findings imply that prebiotic supplementation may support mucosal healing and improve Gln availability, potentially enhancing gut barrier function and nutrient utilization in pediatric CD patients (Drabiska et al
